会員になる

カート (0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

InterContinental San Francisco

2018年11月05日 (月) 午前 7:00 - 2018年11月06日 (火) 午後 3:00

888 Howard Street, San Francisco, CA 94103

Real World Evidence Conference

This conference has reached maximum capacity.

戻る Agenda

Session 1: Landscape Analysis of Real World Evidence and Current Regulatory Frameworks

Session Chair(s)

Mark Stewart, PhD

Mark Stewart, PhD

Vice President, Science Policy

Friends of Cancer Research, United States

This session will introduce the concept of real-world data and evidence and provide an overview of the current landscape. The session will be divided into two components: regulatory use of real world evidence and sources, and applications of RWD/RWE.

Learning Objective : At the conclusion of this session, participants should be able to:
Assess the scope of the conference
Describe the sources of real world evidence
Explain how RWE can contribute to drug development

Speaker(s)

Jacqueline A. Corrigan-Curay, JD, MD

FDA Update

Jacqueline A. Corrigan-Curay, JD, MD

FDA, United States

Principal Deputy Center Director, Center for Drug Evaluation and Research (CDER)

Morgan Romine, MPA

Updates on Conceptual Frameworks for Regulatory Use

Morgan Romine, MPA

Duke University, United States

Chief of Staff